Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MDA-MB-134-VI | AZD2014 | 10.0 | -0.7122 | 0.26896 |
| HCC1395 | THZ1 | 1.0 | -0.7138 | 0.30744 |
| SUM1315MO2 | THZ1 | 1.0 | -0.7186 | 0.25478 |
| HCC1500 | GSK2334470 | 10.0 | -0.7194 | -0.18701 |
| HCC1500 | Senexin B | 0.1 | -0.7194 | -0.10529 |
| MDA-MB-361 | LY3023414 | 3.16227766017 | -0.7200 | 0.29233 |
| MDA-MB-134-VI | THZ531 | 0.1 | -0.7201 | 0.29420 |
| SK-BR-3 | THZ1 | 1.0 | -0.7210 | 0.42181 |
| HCC70 | MK 1775 | 10.0 | -0.7213 | 0.40409 |
| HCC70 | THZ531 | 0.316227766 | -0.7222 | 0.47949 |
| HCC1500 | RO-3306 | 0.316227766017 | -0.7266 | -0.11484 |
| HCC70 | THZ531 | 0.316227766 | -0.7267 | 0.46994 |
| HCC1500 | Senexin B | 1.0 | -0.7302 | -0.18873 |
| HCC1395 | THZ1 | 1.0 | -0.7322 | 0.36460 |
| MDA-MB-361 | THZ531 | 0.316227766017 | -0.7331 | 0.17190 |
| MDA-MB-361 | LY3023414 | 3.16227766017 | -0.7338 | 0.21499 |
| HCC1428 | Senexin B | 0.01 | -0.7356 | 0.08458 |
| MDA-MB-134-VI | LY3023414 | 3.16227766017 | -0.7357 | 0.32782 |
| HCC1500 | MK 1775 | 1.0 | -0.7372 | -0.11696 |
| HCC1428 | LY3023414 | 10.0 | -0.7374 | 0.08047 |
| MDA-MB-361 | THZ1 | 1.0 | -0.7383 | 0.17036 |
| HCC1500 | Senexin B | 1.0 | -0.7406 | -0.08927 |
| HCC70 | LY3023414 | 10.0 | -0.7413 | 0.39744 |
| MDA-MB-361 | THZ1 | 1.0 | -0.7415 | 0.20514 |
| SK-BR-3 | Alvocidib | 1.0 | -0.7421 | 0.57909 |